University of Italian Switzerland
University of Italian Switzerland
Location: Lugano - Ticino
Smartphones and social media are part of our lives, raising understandable concerns, especially when younger people use them. However, online experiences can be as negative as they are positive. The way to the psychological well-being of adults and adolescents is through the conscious use of such technologies, not their avoidance. This is one of the results of the HappyB research project, supported by the Swiss National Science Foundation and carried out in collaboration with Università della Svizzera italiana and the Harvard T.H. Chan School of Public Health. The project leader is Laura Marciano, post-doctoral researcher.
Flora Ruchat-Roncati (1937-2012) was one of the leading lights of Swiss architecture in the second half of the 20th century. Part of the new generation of architects from Ticino with Aurelio Galfetti, Ivo Trümpy, Luigi Snozzi, Livio Vacchini and Mario Botta, Flora Ruchat-Roncati was the first full professor of planning at the Swiss Federal Institute of Technology Zurich in 1985. Her works include the schools in Riva San Vitale, the Bagno di Bellinzona (both with Galfetti and Trümpy), and the A16 Transjurane motorway infrastructure designed with Renato Salvi between 1989 and 1998, and her collaboration with the Beratungsgruppe für Gestaltung for AlpTransit.
Researchers at the Institute of oncology research (IOR, affiliated to USI and member of Bios+ ) , in collaboration with researchers from the University of Padova, have made a groundbreaking discovery that could change the way we think about ageing and immune cells offering a potential new target for treatments in cases of prostate cancer. The study is published in the prestigious journal Cancer Cell.
The coronavirus keeps evolving, and in doing so, it evades our immune defences. But does the entire coronavirus evolve, or do some portions remain unchanged? Sieving through over 10 million coronavirus sequences, two PhD students at the Institute for Research in Biomedicine (IRB, Switzerland, affiliated with the Università della Svizzera italiana) discovered that some portions of the virus spike (the molecule on the virus that is key to infect human cells) were remarkably conserved.
The Experimental Therapeutics group , directed by Prof. Carlo V. Catapano at the Institute of Oncology Research (IOR, affiliated to USI and member of Bios+), in collaboration with Prof. Jonathan Hall at the Swiss Federal Institute of Technology in Zürich (ETH, Zurich) identified a novel mechanism for the treatment of hepatic disorders of abnormal lipid deposition.
The USI-affiliated Institute of Oncology Research (IOR) has reached a licensing agreement with BIMINI Biotech, a startup from the Netherlands, to acquire and further develop a novel first-in-class Wiskott Aldrich Syndrome protein (WASp) activator.
The national jury of the fifth edition of the Boldbrain Startup Challenge awarded first prize to Aliper Therapeutics, a spin-off of the USI-affiliated Institute of Oncology Research (IOR) in Bellinzona. We talked about it with Nicolò Pernigoni, postdoc at the IOR.
A new research project conducted by Professor Laurent Frésard of USI Faculty of Economics has been approved by the Swiss National Science Foundation (SNSF) . The study "Sustainable Investing, Information, and Real Effects" focuses on sustainable investments, i.e., investments that take into account financial objectives and environmental, social, and governance effects. Sustainable investing is becoming increasingly popular and is therefore considered an important tool for promoting the transition to a more sustainable economy. The involvement of investors interested not only in financial returns would lead companies to pursue environmental and social goals as well as economic ones.
The Astrophysical Spectropolarimetry research project, led by Renzo Ramelli of the USI-affiliated Istituto ricerche solari Aldo e Cele Daccò (IRSOL), has been approved by the Swiss National Science Foundation (SNSF). The project aims to study the evolution and structure of the solar magnetic field, focusing on the formation of solar flares using modern equipment and innovative observation techniques.
In 2021, public research institutes in Switzerland managed nearly 3,500 research contracts with public and private partners, filed 335 patent applications and created 83 spin-offs. These are the main results of the annual report of the Swiss Technology Transfer Association (swiTT), which collected data from the two Federal Institutes of Technology, eight universities, seven universities of applied sciences and two research institutes.
The Pfizer Prize Foundation awarded 11 studies and 21 researchers, including Dr Nicolò Pernigoni, Dr Elena Zagato and Professor Arianna Calcinotto of the Oncology Research Institute (IOR) and Dr Fernando P. Canale, Dr Camilla Basso and Professor Roger Geiger of the Institute for Research in Biomedicine (IRB).
A new research project led by Luca Gambardella, professor at the Dalle Molle Institute for Artificial Intelligence IDSIA (USI-SUPSI) and Pro-Rector for Innovation and Corporate Relations, has been approved by the Swiss National Science Foundation (SNSF) . The study entitled 'Computational methods for integrality gaps analysis' approaches the optimisation of algorithms to deal with complex problems from an innovative and original perspective.
The Swiss university libraries and the publisher Oxford University Press (OUP) have concluded a two-year Read&Publish agreement. Publish part From January 2023, USI researchers will be able to publish Open Access (OA) articles in hybrid journals (Hybrid Open Access) of the publisher OUP free of charge, provided they are corresponding authors of the article and under contract with USI.
A new research project led by Professor Alberto Plazzi, director of the Master in Finance at USI Faculty of Economics, has received positive feedback from the Swiss National Science Foundation (SNSF ). The study "The Determinants and Corporate Implications of Credit Derivatives: Evidence from the CDS Market" aims to deepen the understanding of the factors that determine the so-called pricing and trading of credit risk and its consequences on corporate policies and behaviour.